Arcus Biosciences (RCUS) Debt Ratio (2024 - 2026)
Arcus Biosciences (RCUS) posted quarterly Debt Ratio of 0.1 for Q1 2026, up 150.75% year-over-year from 0.04 in Q1 2025, and up 15.4% quarter-over-quarter from 0.09 in Q4 2025.
Analysis
Arcus Biosciences (RCUS) Debt Ratio (2024 - 2026) Analysis & Trends
Arcus Biosciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.1 for Q1 2026.
- In Q1 2026, Debt Ratio rose 150.75% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (up 150.75% YoY), while the FY2025 annual figure was 0.09, up 108.24% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.1, up from 0.09 in the prior quarter.
- The five-year high for Debt Ratio was 0.1 in Q3 2025, with the low at 0.04 in Q3 2024.
- The 3-year median for Debt Ratio is 0.09 (2025), against an average of 0.07.
- Peak annual rise in Debt Ratio reached 178.3% in 2025, while the deepest fall reached 108.24% in 2025.
- Arcus Biosciences' Debt Ratio stood at 0.04 in 2024, then jumped by 108.24% to 0.09 in 2025, then increased by 15.4% to 0.1 in 2026.
- Business Quant data shows RCUS's Debt Ratio at 0.1 in Q1 2026, 0.09 in Q4 2025, and 0.1 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 0.47 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 0.26 |
| 10 | Arcus Biosciences | 3.73 Bn | 3.03 Bn | - | 0.11 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.11 |
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.09 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.04 |